CS logo
small CS logo
Chestnut Hill Healthcare Cancer Center

Philadelphia, Pennsylvania, United States

About Chestnut Hill Healthcare Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Chestnut Hill Healthcare Cancer Center


During the past decade, Chestnut Hill Healthcare Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Chestnut Hill Healthcare Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Chestnut Hill Healthcare Cancer Center


According to Clinical.Site data, the most researched conditions in "Chestnut Hill Healthcare Cancer Center" are "Breast Cancer" (2 trials). Many other conditions were trialed in "Chestnut Hill Healthcare Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Chestnut Hill Healthcare Cancer Center


Most popular intervention types in "Chestnut Hill Healthcare Cancer Center" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials), "Gemcitabine" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chestnut Hill Healthcare Cancer Center


The vast majority of trials in "Chestnut Hill Healthcare Cancer Center" are 2 trials for "Female" genders.

Clinical Trials Status at Chestnut Hill Healthcare Cancer Center


Currently, there are NaN active trials in "Chestnut Hill Healthcare Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chestnut Hill Healthcare Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chestnut Hill Healthcare Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".